Index Overview

Akros SCHK HK-Korea Cosmetics Index

Index Value1,049.0952.322(0.22%)

Index Value1,049.0952.322(0.22%)

TickerASHKCOS

CurrencyHKD

PublishedMar 29, 2026

TickerASHKCOS

CurrencyHKD

PublishedMar 29, 2026

Recent Key Events

HLB Co Ltd (028300)

9/27/2026

The U.S. FDA has granted Priority Review and set a PDUFA target action date of September 27, 2026, for its decision on the New Drug Application (NDA) for Lirafugratinib as a second-line treatment for cholangiocarcinoma (bile duct cancer); a high price impact is expected as a key regulatory milestone, which is scheduled.

Other

Description

Performance Comparison

Return by Period

Last updated: 4/17/2026

1 Month

7.81%

3 Months

3.46%

1 Year

36.30%

3 Years

26.26%

Dividend & Premium

Loading dividend & premium...

Latest Top 10 Holdings

Industry Exposure

Detail:

Documents

Index Value (Last 3 Months)

Recent Key Events

HLB Co Ltd (028300)

9/27/2026

The U.S. FDA has granted Priority Review and set a PDUFA target action date of September 27, 2026, for its decision on the New Drug Application (NDA) for Lirafugratinib as a second-line treatment for cholangiocarcinoma (bile duct cancer); a high price impact is expected as a key regulatory milestone, which is scheduled.

Other

Documents

Latest Top 10 Holdings

Industry Exposure

Detail: